FDA Clears New Drug-Sparing Option for HIV Infection FDA Clears New Drug-Sparing Option for HIV Infection

The dolutegravir and lamivudine combination (Dovato) is the first once-daily, single-tablet, two-drug regimen for adults with treatment-naive HIV infection.Medscape Medical News
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Alert Source Type: news